Biocryst Pharmaceuticals reported $101.2M in Current Liabilities for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Chemocentryx CCXI:US $ 55.38M 0.65M
Chugai Pharma 4519:JP Y 205910M 61807M
Daiichi Sankyo 4568:JP Y 332771M 20800M
Enanta Pharmaceuticals ENTA:US $ 28.62M 2.01M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Glaxosmithkline GSK:US $ 21387M 1112M
Intra Cellular Therapies ITCI:US $ 50.42M 10.72M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Karyopharm Therapeutics KPTI:US $ 58.12M 3.88M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novavax NVAX:US $ 1651.52M 442.96M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
YTE INCY:US $ 660.32M 36.44M
Zogenix ZGNX:US $ 69.34M 10.81M